Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | TH1902 |
| Synonyms | |
| Therapy Description |
TH1902 is a peptide-drug conjugate comprising a peptide targeting SORT1 linked to docetaxel, which potentially inhibits tumor growth (PMID: 34314556). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| TH1902 | Sudocetaxel zendusortide|TH 1902|TH-1902|TH19P01-Docetaxel | TH1902 is a peptide-drug conjugate comprising a peptide targeting SORT1 linked to docetaxel, which potentially inhibits tumor growth (PMID: 34314556). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT04706962 | Phase I | TH1902 | TH1902 in Patients With Advanced Solid Tumors | Active, not recruiting | USA | CAN | 0 |